117 results on '"Minssen, Timo"'
Search Results
2. The Dynamic Context and Multiple Challenges of Data Sharing
3. Addressing Exclusivity Issues: COVID-19 and Beyond
4. Evidence-based IP research
5. Using compulsory licences as a governance tool: The need for greater effectiveness and policy coherence
6. Introduction: The Significance of ELSPI Perspectives in Governing, Protecting, and Regulating the Future of Genome Editing
7. Technology-Driven Disruption of Healthcare and ‘UI Layer’ Privacy-by-Design
8. The Ethics and Laws of Medical Big Data
9. Volume Introduction
10. The Interaction of the Medical Device Regulation and the GDPR
11. Identifying the Key Features of an Effective Non-Discrimination Policy: A Delphi Study
12. CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations
13. Ethische und rechtliche Herausforderungen digitaler Medizin in Pandemien
14. The Challenges for Regulating Medical Use of ChatGPT and Other Large Language Models
15. Non-fungible tokens as a framework for sustainable innovation in pharmaceutical R&D: a smart contract-based platform for data sharing and rightsholder protection
16. The Harmonization and Protection of Trade Secrets in the EU
17. Rules and Tools in the Battle Against Superbugs—A Call for Integrated Strategies and Enhanced International Collaboration to Promote Antimicrobial Drug Development
18. An appraisal of the EU Directive on Trade Secrets
19. List of contributors
20. AIRR data under the EU Trade Secrets Directive: aligning scientific practices with commercial realities
21. Ethical and legal challenges of artificial intelligence-driven healthcare
22. Ethical perspectives on surgical video recording for patients, surgeons and society: systematic review
23. Global Genes, Local Concerns
24. Legal issues and underexplored data protection in medical 3D printing: A scoping review
25. Towards Responsible Quantum Technology
26. Repositioning Generic Drugs: Empirical Findings and Policy Implications
27. 3D Printing, Intellectual Property Rights and Medical Emergencies: In Search of New Flexibilities
28. Intellectual property in quantum computing and market power: a theoretical discussion and empirical analysis
29. Mapping the Patent Landscape of Quantum Technologies: Patenting Trends, Innovation and Policy Implications
30. Incentivizing the sharing of healthcare data in the AI Era
31. Balancing Innovation, ‘Ordre Public’ and Morality in Human Germline Editing: A Call for More Nuanced Approaches in Patent Law
32. Governing, Protecting, and Regulating the Future of Genome Editing: The Significance of ELSPI Perspectives
33. AI Insurance: How Liability Insurance Can Drive the Responsible Adoption of Artificial Intelligence in Health Care
34. How NFTs could transform health information exchange
35. Interchangeability of biosimilars: A study of expert views and visions regarding the science and substitution
36. Using the International Pandemic Instrument to Revitalize the Innovation Ecosystem for Antimicrobial R&D
37. Non-Fungible Tokens as a Framework for Sustainable Innovation in Pharmaceutical R&D: A Smart Contract-Based Platform for Data Sharing and Rightsholder Protection
38. Supplementary Measures and Appropriate Safeguards for International Transfers of Personal Data after Schrems II
39. A Pandemic Instrument Can Start Turning Collective Problems into Collective Solutions by Governing the Common-Pool Resource of Antimicrobial Effectiveness
40. More competition-law-FRANDly IPR policies: a solution to SSOs’ problems of self-governance?
41. Cross-Border Transfers of Personal Data After Schrems II: Supplementary Measures and new Standard Contractual Clauses (SCCs)
42. Ecosystem effectuation: creating new value through open innovation during a pandemic
43. The Genetic Discrimination Observatory: confronting novel issues in genetic discrimination
44. Collaboration in times of crisis: A study on COVID-19 vaccine R&D partnerships
45. Standardization, IPRs and open innovation in synthetic biology
46. The Patentability of Computer-Implemented Simulations and Implications for Computer-Implemented Inventions (CIIs)
47. Evolving Biosimilar Clinical Requirements: A Qualitative Interview Study with Industry Experts and European National Medicines Agency Regulators
48. Tackling Grand Challenges with Competition Law: Lessons from the Pandemic
49. Addressing Exclusivity Issues During the COVID-19 Pandemic and Beyond
50. US U-Turn on COVID IP Waiver Alone Will Not Solve Vaccine Crisis – Intellectual Property Is an Important Part of the Debate, but Greater Transparency Is Required
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.